Search results

24 items matching your search terms.
Filter the results.
Item type











New items since



Sort by relevance · date (newest first) · alphabetically
Ben Philpot receives new R01 funding
Located in News
The work of Mark Zylka, PhD, and Ben Philpot, PhD, is featured by Autism Speaks in its list of 10 major advances in autism research in 2013.
Located in News
August 2013 - Findings published in the journal Nature outline the effects that key enzymes called topoisomerases can have on the genetic machinery behind brain development.
Located in News
Thaxton awarded two-year NARSAD Young Investigator grant
The Brain & Behavior Research Foundation (formerly known as NARSAD, or the National Alliance for Research on Schizophrenia and Depression) awards $11.8 million in 200 new two-year grants for young researchers in brain and behavior science.
Located in News
November 2012 - New research from Ben Philpot and colleagues provides a neurological justification for this therapeutic approach, but researchers caution there could be unanticipated effects.
Located in News
Philpot lab publishes cover story in the journal Neuron
October 2012 - A new activity-dependent role for the protein heavily implicated in autism, Neuroligin-1, identified
Located in News
Located in News
Philpot lab publication in the journal Neuron outlines how brain cell activity imbalance may account for seizure susceptibility in Angelman syndrome
New research by Philpot lab researchers may have pinpointed an underlying cause of the seizures that affect 90 percent of people with Angelman syndrome (AS), a neurodevelopmental disorder.
Located in News
Rylan Larsen and Michael Wallace accepted to Marine Biological Laboratory summer courses
Philpot lab graduate students Rylan Larsen and Michael Wallace will attend Marine Biological Laboratory (MBL) courses this summer in Woods Hole, Maine, and each has received a scholarship from the MBL.
Located in News
Philpot and Snider awarded $2 million to study roots of cognitive disabilities
April 2012 -Philpot and Snider will study the cognitive disabilities in patients with RAS/MARK syndromes.
Located in News